Edition:
United States

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

0.57USD
15 Dec 2017
Change (% chg)

$-0.04 (-6.48%)
Prev Close
$0.61
Open
$0.62
Day's High
$0.62
Day's Low
$0.56
Volume
82,064
Avg. Vol
82,652
52-wk High
$2.15
52-wk Low
$0.56

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Paul Geyer

2008 Independent Chairman of the Board

Alexei Marko

2008 Chief Executive Officer, Director

Christopher Clark

2015 Chief Financial Officer, Corporate Secretary

Brian McPherson

2009 Chief Operating Officer

Vicki Bebeau

2014 Vice President - Clinical Affairs